Reuters logo
BRIEF-Tonix Pharma announces issuance of U.S. patent for TNX-102 SL composition and formulation
May 2, 2017 / 11:22 AM / in 5 months

BRIEF-Tonix Pharma announces issuance of U.S. patent for TNX-102 SL composition and formulation

May 2 (Reuters) - Tonix Pharmaceuticals Holding Corp

* Tonix pharmaceuticals announces issuance of u.s. Patent for tnx-102 sl composition and formulation designed for transmucosal absorption, bedtime daily use Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below